Dallas PCI: Coronary Imaging and Physiology

Dr. Dib is board certified in cardiovascular disease and interventional cardiology. In addition, he has completed extensive training in nuclear cardiology and is certified by the Certification Board of Nuclear Cardiology. His clinical interests include coronary artery disease and interventions, peripheral artery disease and interventions, structural heart disease, venous disease, ablation, thrombectomy, pacemaker implantation and interrogation. After finishing his internship and residency training at Mayo Clinic, Dr. Dib went on to complete a fellowship in Cardiovascular Disease at the University of Oklahoma Health Sciences Center in Oklahoma City and a fellowship in Interventional Cardiology at the University of Texas Health Science Center in Houston. He is also a fellow of the American College of Cardiology and the Society of Cardiac Angiography and Interventions. Dr. Dib is on the medical staff at The Heart Hospital Baylor Plano and Baylor Scott & White Medical Center – McKinney. He is currently welcoming new patients.

Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.

Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos / Complutense University of Madrid, Spain. He is author of over 450 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 67), Deputy Editor of the European Heart Journal and editor of the textbooks “Coronary Stenosis. Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation). Recent trials as principal investigator include ADVISE II, DEFINE FLAIR and SYNTAX II. As an educationalist, he frequently serves as lecturer and live case operator at major scientific meetings.

Interventional cardiologist and entrepreneur taking products from inception to commercialisation. Justin now is Founder & CEO of Wondr Medical, a medical technology company which is revolutionising communications for the medical community. Justin developed algorithms (iFR), which are used on Volcano-Philips systems in hospitals all around the world to aid diagnosis and treatment of coronary artery disease.

Dr. Al-Azizi is board-certified in interventional cardiology and cardiovascular disease. In addition, he has completed extensive training in structural heart disease and interventions. He specializes in valvular heart disease, transcatheter valve interventions (e.g. TAVR), left atrial appendage closure, coronary angiography, complex percutaneous coronary interventions (PCI), peripheral vascular disease and interventions. His expertise also includes advanced cardiac imaging technology, including computed tomography (CT), nuclear cardiology, echocardiography and coronary imaging and physiology.

Dr. Molly Szerlip is the Medical Director of the Inpatient and Outpatient Valve Service Program and the Program Director for the Structural Fellowship at Baylor Scott & White/The Heart Hospital in Plano, TX. Dr. Szerlip practices at Baylor Scott & White-The Heart Group in Plano, TX. Dr. Szerlip was an Assistant Professor of Medicine and Surgery at the University of Arizona before moving to Texas and joining The Heart Group.

Sameh Sayfo, MD, RPVI is an interventional cardiologist with Legacy Heart Center. He specializes in the management of cardiac diseases including atrial fibrillation, coronary artery disease, peripheral arterial and venous disease, and heart failure. His areas of expertise include complex coronary and peripheral artery interventions, atrial septal defect and patent foramen ovale closures, aortic valve treatment including valvuloplasty and transcather aortic valve replacement (TAVR), as well as endovascular aortic repair (EVAR) and carotid stenting. Dr. Sayfo is certified by the National Board of Echocardiography and he is a Registered Physician in Vascular Interpretation (RPVI) certified by the American Registry for Diagnostic Medical Sonography. He is also specially trained in venous ablation, treating venous diseases including varicose and spider veins using both endovenous laser treatment (EVLT) and radiofrequency ablation. In addition, he is active in clinical research and has a special interest in interventional cardiology studies. Dr. Sayfo is on the medical staff at The Heart Hospital Baylor Plano, Baylor Regional Medical Center at Plano, and Baylor Medical Center at McKinney. He is currently welcoming new patients.

Srini Potluri, MD, FACC joined Legacy Heart Center from the Ochsner Clinic Foundation in New Orleans, Louisiana where he was Chief Interventional Fellow and was on the Foundation’s interventional staff. He completed fellowships in cardiology, interventional cardiology and heart failure and cardiac transplantation at the Ochsner Clinic Foundation as well. He specializes in carotid stenting and the closure of the atrial septal defect and patent foramen ovale. Both procedures are innovative stroke prevention strategies that provide patients minimally invasive alternatives to surgery. Carotid stenting provides patients who are a high risk for surgery an alternative to the carotid endarterectomy procedure. The closure of the atrial septal defect and patent foramen ovale provides patients with an alternative to open heart surgery. Because both procedures are less invasive than traditional surgeries, patients are usually discharged the next day. He also serves as the head of the Legacy Heart Center Vein and Vascular Clinic and is the medical director of the catheterization laboratory at The Heart Hospital Baylor Plano. Dr. Potluri is board certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology. Prior to his work at Ochsner, he served as a Chief Resident at New York Methodist Hospital Cornell Medical Center, where he was named resident of the year for 1999-2000. He received his medical degree from Osmania Medical College in Hyderabad, India and served internships at Methodist Hospital and Osmania General Hospital, where he was named as best intern. He has received the Charles B. Moore Research Award for outstanding research achievement from the Department of Cardiology at Ochsner; a certificate for scholarly achievement from the department of Internal Medicine; and a Certificate of Merit from the Physician Alumni Association at Methodist Hospital.